A
ATAI Life Sciences
Biotech & Life Sciences · Berlin, Germany · Founded 2018 · IPO 2021
Investors
21 investors on ATAI Life Sciences's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
ATAI Life Sciences mafia
Startups founded by ATAI Life Sciences alumni
Former ATAI Life Sciences employees who went on to start their own companies. Sorted by Dealroom signal score.
Global footprint
Where ATAI Life Sciences has talent and traffic
across markets
Talent graph
The shape of ATAI Life Sciences's talent
Dealroom maps ATAI Life Sciences's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$12M patent portfolio · 77 active families
Where ATAI Life Sciences concentrates vs peers
Each axis is a top-10 topic across ATAI Life Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
ATAI Life Sciences's 9 investments and acquisitions.
Every disclosed deal where ATAI Life Sciences appeared as a backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
9 deals across ATAI Life Sciences's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where ATAI Life Sciences deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
ATAI Life Sciences's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about ATAI Life Sciences
An AI-synthesized read of the highest-engagement posts about ATAI Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ATAI Life Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.